OrbiMed goes big on heels of two strong funds

Pills of All Kinds
Healthcare specialist sets $950 mln target for Fund VI; OrbiMed’s $735 mln 2013 vintage fund a top performer for CalSTRS OrbiMed Advisors is targeting $950 million for its latest private equity and venture capital fund on the back of a remarkably strong recent ...
FUNDRAISERS: Don't miss Emerging Manager Connect West 2018 in San Francisco on May 1! CLICK FOR DETAILS!

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition


To read a digital copy of our latest magazine

click here

PE News Briefs